key: cord-0721788-lur2y6bl
authors: Monticelli, Maria; Mele, Bruno Hay; Andreotti, Giuseppina; Cubellis, Maria Vittoria; Riccio, Guglielmo
title: Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19
date: 2021-04-16
journal: Eur J Med Genet
DOI: 10.1016/j.ejmg.2021.104227
sha: e82022fa9d5d29ddf51bb55669449e1b946afbe6
doc_id: 721788
cord_uid: lur2y6bl

The identification of high-risk factors for the infection by SARS-CoV-2 and the negative outcome of COVID-19 is crucial. The genetic background of the host might account for individual responses to SARS-CoV-2 infection besides age and comorbidities. A list of candidate polymorphisms is needed to drive targeted screens, given the existence of frequent polymorphisms in the general population. We carried out text mining in the scientific literature to draw up a list of genes referable to the term “SARS-CoV*”. We looked for frequent mutations that are likely to affect protein function in these genes. Ten genes, mostly involved in innate immunity, and thirteen common variants were identified, for some of these the involvement in COVID-19 is supported by publicly available epidemiological data. We looked for available data on the population distribution of these variants and we demonstrated that the prevalence of five of them, Arg52Cys (rs5030737), Gly54Asp (rs1800450) and Gly57Glu (rs1800451) in MBL2, Ala59Thr (rs25680) in CD27, and Val197Met (rs12329760) in TMPRSS2, correlates with the number of cases and/or deaths of COVID-19 observed in different countries. The association of the TMPRSS2 variant provides epidemiological evidence of the usefulness of transmembrane protease serine 2 inhibitors for the cure of COVID-19. The identified genetic variants represent a basis for the design of a cost-effective assay for population screening of genetic risk factors in the COVID-19 pandemic.

Many people affected by COVID-19 develop fever, cough, fatigue, shortness of breath, muscular pain, and headache. In the most severe cases medical conditions, such as respiratory failure, occur and eventually lead to death.

Age and comorbidities, such as cardiovascular diseases, diabetes, and chronic lung diseases, are known risk factors for worse outcomes (Fang et al., 2020) . Furthermore, altered biomarkers, namely C-reactive Protein, high-sensitivity troponin T, prothrombin time, fibrin degradation products, D-Dimer, and CD4+ count, help differentiate patients who will develop severe symptoms from those who will only be mildly affected (Zheng et al., 2020) . These factors alone are not sufficient to identify all subjects at high risk, and on top of that, they tend to overlap. Genetic factors, on the other hand, also influence risks associated with COVID-19 but are more likely to be independent of age-related comorbidities. Specific studies on the subject are very few and in most cases genes have been selected regardless of the existence of frequent polymorphisms in the general population, lowering their potential as markers for large scale genetic screenings (Hussain et al., 2020) .

SARS-CoV-2 and SARS-CoV belong to the Betacoronavirus genus (Chen et al., 2020) and share the same cellular receptor, the angiotensin-converting enzyme 2 (ACE2), and very similar nucleotide sequences (Yan et al., 2020) .

In this paper, we carried out a bioinformatic analysis to predict polymorphisms that could either influence the acquisition or the course of COVID-19. Text mining was carried out to extract a list of human genes that have been associated with the term "SARS-CoV*" in the literature. We highlighted the polymorphisms of these genes that are very frequent in the general population and are likely to affect the function of the mutated protein. We hope that our prediction can guide and speed up experimental tests and help to find those high-risk subjects that have not been recognized by age, co-morbidities, or biomarkers so far. High variability of symptoms and outcomes characterizes SARS-CoV-2 infection. The phenotypic spectrum of the disease ranges from asymptomatic individuals to patients requiring ventilation due to severe pneumonia (García, 2020). Different hypotheses have been put forward, the role of the host's genetic background is currently emerging (Godri Pollitt et al., 2020; Latini et al., 2020; Strafella et al., 2020; Zhang, S.-Y. et al., 2020) . Data from a genomewide association (GWAS) study involving 1980 patients with COVID-19 and 2381 healthy control participants in Spain and Italy have been recently published (Group, 2020) .Two loci were strongly associated to susceptibility to SARS-CoV-2, one on chromosome 9 covering the ABO blood group and another one on chromosome 3 covering six genes, SLC6A20, LZTFL1, CCR9, FYCO1, CXCR6, and XCR1.

We would like to contribute to gene-specific candidate-driven studies by suggesting missense variants that can cause severe symptoms or facilitate the infection and expand the list of identified by GWAS studies . We evaluated missense mutations that are frequent in the general population and occur in genes that do not cause haploinsufficiency. We selected those that are deleterious for the protein product and we excluded those associated to blood groups. A deleterious mutation on a single allele might not be enough to cause a life-threatening disease and hence it could be relatively frequent but might confer special sensitivity or resistance to viral infection. We excluded variants occurring in promoters, introns, or untranslated regions because their deleteriousness is less predictable. Hence our study will provide a subset of the genetic variants that are likely to affect the sensitivity to infection or the course of COVID-19.

We obtained from the Exome Aggregation Consortium (ExAC) a list of human genes (14995) with a pLI <0.9. pLI is a value that measures the probability of being loss-of-function intolerant (pLI).

Genes with a pLI <0.9 have a low probability of causing haploinsufficiency when affected by the J o u r n a l P r e -p r o o f severe mutation. We developed a simple pipeline to use such a list of genes and corresponding proteins as input and look within the Scopus database for papers containing any of these protein names and the term "SARS-CoV*" in the article's title, abstract, or keywords. The script, which is written in R language and exploits the rscopus package, is provided in Supplementary File S1. We excluded the genes covered by the GWAS analysis (Group, 2020) obtained a "SARS-CoV* referable genes" list (106 genes; Supplementary File S2).

We searched within GnomAD for frequent variants, missense or loss-of-function, in "SARS-CoV* referable genes", setting the threshold to allele frequency at 1%. Lastly, we used Polyhen2 (http://genetics.bwh.harvard.edu/pph2/), to exclude benign mutations. Frequent missense variants were found in 56 genes and deleterious frequent deleterious variants in ten genes. The scheme of the search is provided in figure 1.

The list of identified variants with their frequencies is reported in Table 1 . We observed that the candidate variants were mostly in genes involved in innate immune defense. References to databases and programs utilized in this analysis are provide as a supplementaty file S3.

Data on the prevalence in different populations were available for six of our candidate variants. The datasets relative to rs12329760 (Val197Met, TMPRSS2), rs25680 (Ala59Thr, CD27), and rs3775291 (Leu412Phe, TLR3) were found in ALFRED; the data relative to the MBL2 variants rs5030737 (Arg52Cys), rs1800450 (Gly54Asp), and rs1800451 (Gly57Glu) were reported by Verdu et al. Data on the population distribution of the remaining six variants were not available.

Notwithstanding the limitations associated with publicly available data on the number of cases and J o u r n a l P r e -p r o o f deaths per country that are influenced by socio-economic factors, we found interesting results for five variants, namely Arg52Cys (rs5030737), Gly54Asp (rs1800450), and Gly57Glu (rs1800451) in MBL2, Val197Met (rs12329760) in TMPRSS2 and Ala59Thr (rs25680) in CD27.

MBL2 encodes a mannose-binding protein C that binds mannose, fucose, and N-acetylglucosamine on different microorganisms and activates the lectin complement pathway. The deficiency of mannose-binding protein C (MIM #614372) is associated with increased susceptibility to infection (Degn et al., 2011) . MBL2 binds and activates the lectin complement pathway in viral infections such as HIV (Garred et al., 1997) and influenza (Kase et al., 1999) . We tested three frequent missense mutations in MBL2: Gly54Asp (rs1800450), Arg52Cys (rs5030737), and Gly57Glu (rs1800451). All these mutations affect the ability of the protein to bind carbohydrate surfaces and MASP-2, the mannan-binding lectin serine protease 2 which activates the complement system (Turner, 2003) ; the lowest interaction is observed with Arg52Cys (Larsen et al., 2004) . In a study conducted in China, it was proven that Gly54Asp (rs1800450) is significantly associated with susceptibility to SARS-CoV infection but not with disease severity (Ip et al., 2005; Zhang et al., 2005) ; unfortunately, the other two variants were not tested. We found that the allele frequency per population of Arg52Cys (rs5030737) This finding supports the hypothesis that mannose-binding protein C plays a protective role and that MBL2 inactivation is a risk factor for SARS-CoV-2 infection, and that the immune response plays a role in the course of the disease. infections (Shoenfeld, 2020) . We observed a statistically significant negative correlation between the allele frequency of Ala59Thr and the number of deaths per country [p-value 0.0337] (fig. 5,   panel B ), but not with the numbers of cases ( fig. 5 panel A) .

As discussed above, the association between six inactivating variants (Table 1) The role of ACE in innate immunity has been reviewed (Bernstein et al., 2018) . A very frequent intronic insertion/deletion I/D polymorphism influences ACE expression (Rigat et al., 1990) . A recent paper has suggested the usage of ACE I/D polymorphisms for the identification of high-risk COVID-19 patients (Delanghe et al., 2020) . The hypothesis that variants of ACE are associated with COVID-19 risks is very interesting and is in line with several observations. Although ACE2, rather than ACE, has been identified to be one of the receptors of the SARS-CoV-2, it has been proposed that the unbalance between ACE and ACE2 expression leads to lung injury(Guo et al., 2020).

Children, who have higher levels of ACE than adults, are much less affected by COVID-19 (Guo et al., 2020) . ACE inhibitors have been proven to upregulate ACE2, and some authors speculate a possible role of these extremely commonly used drugs in infection. Their role in COVID-19 disease, however, is very controversial, because upregulation of ACE2 may have a protective role against lung inflammation and fibrosis (Guo et al., 2020) . Publications on ACE I/D polymorphisms and SARS-CoV are of little help because they provide different results (Chan et al., 2005; Itoyama et al., 2004) . A final word on this subject could come from a very recent paper by Richards and coworkers (Butler-Laporte et al., 2020) . Although the authors did not include Tyr244Cys J o u r n a l P r e -p r o o f (rs3730025) in their study, they found that variants which decrease the expression of ACE do not increase COVID-19 susceptibility or severity.

AHSG encodes a protein known as human fetuin which is thought to be an immune modulator, mainly acting on cytokine release from macrophages. Macrophages play a central role in the IL1, 6, TNF alfa, INF gamma dependent cytokine storm. Its deletion has already been linked to worse outcomes in SARS-CoV infected patients (Zhu et al., 2011) .The SNP Ala164Thr is covered by the GWAS study (Group, 2020) and significantly associates with susceptibility to COVID-19 (p-value = 0.05).

The role of GFAP in COVID-19 might be prevalently associated to the severity of the disease and in particular to the development of neurological symptoms. GFAP is a TGF-beta induced gene that participates in the ERG dependent TGF-beta triggering of fibrosis consequent to ROS production. It has been proven that SARS-CoV viruses possess a deubiquitinating protein named PLpro that stimulates such pathway, inducing lung fibrosis in infected patients. Pulmonary fibrosis has been described in cases of SARS-CoV infections, but so far it has not been described to be a relevant feature of the disease (Yang et al., 2006) . Very little is known so far about COVID-19 pathology, and future studies could demonstrate the importance of fibrosis since it is a central feature in uncontrolled activation of macrophage-mediated inflammation. MEFV (Pyrin) is associated to Familial Mediterranean Fever whose symptoms, fever, abdominal/chest pain, elevation of C-reactive protein, and leucocytosis, overlap in part with those of COVID-19. Deleterious variants in this gene might influence the severity of the infection. MEFV is thought to be involved in the NLRP3 dependant IL-1 beta modulation (Manukyan and Aminov, 2016) . The capability of SARS-CoV viruses to activate the NLRP3 inflammasome has already been described (Chen, I.-Y. et al., 2019) . There are some known pathological mutations of MEFV that cause autoinflammatory disease due to a IL1, 6, TNF-alfa INF-gamma cytokine storm (Manukyan and Aminov, 2016) .

Toll like receptors activate Type-I interferon (alpha and beta) response that enhance innate antiviral responses such as the limitation of cell replication, the induction of apoptosis, and the synthesis of enzymes with direct antiviral effect (Kawasaki and Kawai, 2014) . Some viruses have been described to elude the Type I interferon response by shifting the reply towards the Type II (gamma) interferon branch, which favors viral diffusion through tissues by activating a cytokine storm TLR2 might bind SARS-CoV-2 proteins and have a key role in directing the immune response to this pathogen. Arg753Gln (rs5743708) and Pro631His (rs5743704) in TLR2 are relatively frequent in the European population, approximately 3%. A few papers confirm the role of Arg753Gln J o u r n a l P r e -p r o o f (rs5743708) in respiratory diseases (Patarčić et al., 2015) (Smelaya et al., 2016) . The effects of Arg753 substitution by glutamine on TLR2 were proven in vitro. The mutation impairs agonistinduced phosphorylation hetero-dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88 (MYD88) and MyD88 adapter-like (MAL) (Xiong et al., 2012) . The SNP Arg753Gln (rs5743708) is covered in the GWAS study (Group, 2020) and it is associated with COVID-19 significantly (p-value < 0.05). The role in the susceptibility to viral infection is confirmed by the finding that intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in an animal models (Proud et al., 2020) Toll-like receptor 3 is known to be involved in the innate immune response to SARS-CoV infections (Totura et al., 2015) . Its role in the new epidemics is supported by the fact that rare lossof-function variants were found among male patients with life-threatening COVID-19 pneumonia more frequently than in mildly affected controls . One frequent missense mutation in TLR3, Leu412Phe (rs3775291) was associated with several viral diseases (El-Bendary et al., 2018; Fischer et al., 2018; Grygorczuk et al., 2017; Studzińska et al., 2017) . It has an allele frequency ranging from 25% to 35% worldwide except for African populations, where it is 6%.

Although it is necessary to be extremely cautious when considering the causes of the low numbers of reported cases from Africa, nonetheless it is tempting to associate it to the low incidence of rs3775291. Another indication in favour of the role of rs3775291 in the susceptibility to SARS-CoV-2 comes from the GWAS study (Group, 2020) where a significative difference (p-value < 0.03) was observed between affected people and healthy controls.When we analysed the epidemiological data of general European populations, as we did for variants in TMPRSS2 (fig4) or CD27 (fig5), we did not find significant correlation (data not shown), but it would be interesting to look in a cohort of males.

Four deleterious frequent variation were found in the genes identified by GWAS analysis (Group, 2020), although these SNPs were not covered by the study.

Thr199Met in the gene SLC6A20 encoding Sodium-and chloride-dependent transporter XTRP3 and Asp182Asn in the gene LZTFL1 encoding Leucine zipper transcription factor-like protein 1 are relatively frequent in the European population but not in African and East Asian populations.

GluE994Lys and Arg1140Gln are in the gene FYCO1 encoding FYVE and coiled-coil domaincontaining protein 1 that participate in the transportation and maturation of autophagosomes.

COVID-19 pandemic upset the world. The fast spread of SARS-CoV-2 through over the world and some peculiar novelties of the virus, such as the high number of asymptomatic individuals, rendered it a difficult challenge from different aspects. A strong effort was put in the discovery of risk factors associated with a more serious phenotype. Besides this, different countries experienced different impacts caused by SARS-CoV-2. As well described by Yamamoto and Bauer (Yamamoto and Bauer, 2020) , many factors contribute to these differences, e.g. socio-behavioral habits, political management, co-existence with other viruses, genetic factors. Genetic factors can play a major role in defining the outcome of the infection. This correlation is hard to prove due to all the side-factors described above, that certainly influence the official data from the different countries. Moreover, the globalized world we live in certainly complicates the association between population variants and countries. Nevertheless, our data showed that a statistically significant correlation could be proved for some common variants in three genes, namely MBL2, TMPRSS7, and CD27, with the number of cases or deaths observed per country.

These data suggest that the genetic background is of utmost importance in the evaluation of COVID-19 susceptibility and that the discovery of target genes could be useful in the treatment and J o u r n a l P r e -p r o o f The Exome Aggregation Consortium (ExAC) provided a list of human genes and annotated them with a value that measures the probability of being loss-of-function intolerant (pLI). The names of the genes were associated to the names of the corresponding proteins. Such list was used as the input to look within the Scopus database for papers containing any of the protein names and the term "SARS-CoV*" in the article's title, abstract or keywords. "SARS-CoV referable genes", encompassing frequent variants, missense or loss of function, were identified setting the threshold to allele frequency to 1%, and excluding variants that did not pass quality control or occur in non-canonical transcripts. The genes covered by the GWAS analysis (Group, 2020) were excluded. Among these genes, those encompassing frequent deleterious variants were identified. Details about populations and their association to countries are provided in supplementary file S1. 

Update on pyrin functions and mechanisms of familial Mediterranean fever

Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome

The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta-analyses and field synopsis

agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

Corona (COVID-19) time musings: our involvement in COVID-19

pathogenesis, diagnosis, treatment and vaccine planning

Analysis of ACE2 Genetic Variability Among Populations Highlights A Possible Link With COVID19

Association of TLR3

L412F polymorphism with cytomegalovirus infection in children

Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection

The role of mannose-binding lectin in health and disease

R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88

Apparent difference in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: Four hypotheses for possible explanation

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

NG2 glial cells provide a favorable substrate for growing axons

Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity?

Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu

Genetic variation of the human α-2-Heremans-Schmid glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection

ACKNOWLEDGEMENTS: This work is dedicated to our friend and colleague Maria Malanga.FUNDING: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.